Increased 2-hydroxylation of estrogen in women with a family history of osteoporosis.

Giovam Battista Rini, Sirisha Donepudi, Nicola Napoli, Reina Armamento-Villareal, Sharmin Sheikh, Nicola Napoli

    Risultato della ricerca: Articlepeer review

    14 Citazioni (Scopus)

    Abstract

    Recent studies indicate that women with predominant estrogen metabolism through the 2-hydroxyl (inactive) pathway have lower bone mineral density (BMD) compared with those with predominant 16α-hydroxylation (active). Although many factors have been identified to affect estrogen metabolism, the role of a family history of osteoporosis remains unknown. The objective of this study was to investigate the influence of family history of osteoporosis and other clinical factors on estrogen hydroxylation. This was a cross-sectional study conducted in a university-based research center from May 2002 to February 2004. The participants included 175 otherwise healthy postmenopausal women at least 1 yr from the last menstrual period. Main outcome measures were urinary estrogen metabolites and BMD of the spine and femur. Women with a family history of osteoporosis had significantly higher log-transformed ratios of 2-hydroxyestrone/16α-hydroxyestrone (0.303 ± 0.03 vs. 0.226 ± 0.03; P = 0.04) and 2-methoxyestrone/16α-hydroxyestrone (0.024 ± 0.02 vs. −0.036 ± 0.02; P = 0.03) compared with women without family history. As expected, these women also had significantly lower BMD at the total femur, trochanter, and intertrochanter. Surprisingly, calcium intake positively correlated with metabolite levels, and women in the highest quartile of calcium intake had the highest levels of urinary metabolites. In conclusion, women with a positive family history of osteoporosis have predominant estrogen metabolism through the inactive 2-hydroxyl pathway; thus, the increased risk of osteoporosis in those with family history may in part be related to inherited differences in estrogen metabolism. The finding that calcium intake modulates estrogen hydroxylation has never been reported and thus deserves additional investigation
    Lingua originaleEnglish
    pagine (da-a)2035-2041
    Numero di pagine7
    RivistaTHE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    Volume90
    Stato di pubblicazionePublished - 2005

    All Science Journal Classification (ASJC) codes

    • Endocrinology, Diabetes and Metabolism
    • Biochemistry
    • Endocrinology
    • Clinical Biochemistry
    • Biochemistry, medical

    Fingerprint Entra nei temi di ricerca di 'Increased 2-hydroxylation of estrogen in women with a family history of osteoporosis.'. Insieme formano una fingerprint unica.

    Cita questo